Phase
Condition
N/ATreatment
Placebo
OnabotulinumtoxinA
AGN-151586
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Has moderate or severe glabellar lines (GL) at maximum frown as assessed by both theinvestigator and participant using the Facial Wrinkle Scale (FWS).
Must be in good health as per investigator's judgment based on medical history,physical examination, vital sign measurements, 12-lead ECG parameters, clinicallaboratory evaluations, and neurological assessment.
Exclusion
Exclusion Criteria:
Active infection or dermatological condition at the treatment injection sites.
History of immunization to any botulinum neurotoxin serotype or hypersensitivity toany botulinum neurotoxin serotype or any other constituents of the study drug or itsexcipients, and/or other products in the same class.
Study Design
Connect with a study center
Investigate MD /ID# 270771
Scottsdale, Arizona 85260
United StatesActive - Recruiting
Eye Research Foundation /ID# 270827
Newport Beach, California 92663
United StatesActive - Recruiting
Marcus Facial Plastic Surgery /ID# 270770
Redondo Beach, California 90277
United StatesActive - Recruiting
Skin Research Institute LLC /ID# 270831
Coral Gables, Florida 33146-1837
United StatesActive - Recruiting
Skincare Physicians /ID# 271018
Chestnut Hill, Massachusetts 02467
United StatesActive - Recruiting
Wilmington Dermatology Center /ID# 270828
Wilmington, North Carolina 28403
United StatesActive - Recruiting
Austin Institute for Clinical Research - Pflugerville /ID# 270834
Pflugerville, Texas 78660
United StatesActive - Recruiting
SkinDC /ID# 270932
Arlington, Virginia 22209
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.